Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001104659-25-014838
Filing Date
2025-02-18
Accepted
2025-02-18 17:13:52
Documents
109

Document Format Files

Seq Description Document Type Size
1 FORM-S-4 glyc-20241231xs4.htm   iXBRL S-4 6970324
2 EXHIBIT-3.6 glyc-20241231xex3d6.htm EX-3.6 144725
3 EXHIBIT-3.7 glyc-20241231xex3d7.htm EX-3.7 95430
4 EXHIBIT-10.4 glyc-20241231xex10d4.htm EX-10.4 177353
5 EXHIBIT-10.32 glyc-20241231xex10d32.htm EX-10.32 147783
6 EXHIBIT10.33(A) glyc-20241231xex10d33a.htm EX-10.33(A) 106098
7 EXHIBIT-10.33(B) glyc-20241231xex10d33b.htm EX-10.33(B) 81698
8 EXHIBIT-10.34 glyc-20241231xex10d34.htm EX-10.34 159015
9 EXHIBIT-10.35 glyc-20241231xex10d35.htm EX-10.35 121614
10 EXHIBIT-10.36 glyc-20241231xex10d36.htm EX-10.36 107371
11 EXHIBIT-10.37 glyc-20241231xex10d37.htm EX-10.37 105972
12 EXHIBIT-10.38 glyc-20241231xex10d38.htm EX-10.38 85256
13 EXHIBIT-10.39 glyc-20241231xex10d39.htm EX-10.39 82934
14 EXHIBIT-10.40 glyc-20241231xex10d40.htm EX-10.40 86976
15 EXHIBIT-10.41 glyc-20241231xex10d41.htm EX-10.41 226676
16 EXHIBIT-10.42 glyc-20241231xex10d42.htm EX-10.42 238691
17 EXHIBIT-23.1 glyc-20241231xex23d1.htm EX-23.1 1846
18 EXHIBIT-23.2 glyc-20241231xex23d2.htm EX-23.2 1905
19 EXHIBIT-23.4 glyc-20241231xex23d4.htm EX-23.4 7286
20 EXHIBIT-99.1 glyc-20241231xex99d1.htm EX-99.1 6295
21 EXHIBIT-99.2 glyc-20241231xex99d2.htm EX-99.2 4909
22 EXHIBIT-99.3 glyc-20241231xex99d3.htm EX-99.3 4907
23 EXHIBIT-99.4 glyc-20241231xex99d4.htm EX-99.4 5317
24 EX-FILING FEES glyc-20241231xexfees.htm EX-FILING FEES 30041
30 GRAPHIC glyc-20241231xex23d4001.jpg GRAPHIC 5330
31 GRAPHIC glyc-20241231xs4007.jpg GRAPHIC 10447
32 GRAPHIC glyc-20241231xs4008.jpg GRAPHIC 11149
33 GRAPHIC glyc-20241231xs4027.jpg GRAPHIC 67962
34 GRAPHIC glyc-20241231xs4028.jpg GRAPHIC 52956
35 GRAPHIC glyc-20241231xs4029.jpg GRAPHIC 70839
36 GRAPHIC glyc-20241231xs4030.jpg GRAPHIC 20789
37 GRAPHIC glyc-20241231xs4031.jpg GRAPHIC 37692
38 GRAPHIC glyc-20241231xs4032.jpg GRAPHIC 86744
39 GRAPHIC glyc-20241231xs4033.jpg GRAPHIC 58212
40 GRAPHIC glyc-20241231xs4034.jpg GRAPHIC 72698
41 GRAPHIC glyc-20241231xs4035.jpg GRAPHIC 52886
42 GRAPHIC glyc-20241231xs4036.jpg GRAPHIC 73577
43 GRAPHIC glyc-20241231xs4037.jpg GRAPHIC 70505
44 GRAPHIC glyc-20241231xs4053.jpg GRAPHIC 5904
45 GRAPHIC glyc-20241231xs4054.jpg GRAPHIC 7030
46 GRAPHIC glyc-20241231xs4055.jpg GRAPHIC 5011
  Complete submission text file 0001104659-25-014838.txt   16530247

Data Files

Seq Description Document Type Size
25 XBRL TAXONOMY EXTENSION SCHEMA glyc-20241231.xsd EX-101.SCH 43655
26 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glyc-20241231_cal.xml EX-101.CAL 46925
27 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glyc-20241231_def.xml EX-101.DEF 182397
28 XBRL TAXONOMY EXTENSION LABEL LINKBASE glyc-20241231_lab.xml EX-101.LAB 403986
29 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glyc-20241231_pre.xml EX-101.PRE 335807
112 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20241231xs4_htm.xml XML 842432
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-285035 | Film No.: 25636100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)